Pyc Therapeutics Ltd has released a press release.
Response to Price Query
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
Earlier from PYC Therapeutics
- Supplementary Information
- New Drug For Major Kidney Disease Effective In Human Models
- PYC and FDA Align On Clinical Trial Pathway in ADOA
- RP11 Clinical Trial Dosing Completed In Patient Cohort 2
- PYC-001 Effective In Both NHPs and Patient-Derived Models
Later from PYC Therapeutics
- RP11 Clinical Trial Progressing To High Dose Cohort
- AI Driven Drug Discovery Collaboration with Google Cloud
- Receipt of $4.5m Collaboration Fee
- RP11 Clinical Trial - Dosing Completed in Cohort 3
- PYC Equity Raising to Raise up to $74.6 Million
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics